Mayo Clinic IP results in FDA-cleared BodyGuardian remote heart monitoring device
Entrepreneur Jon P. Otterstatter wanted to leverage his prior experience in information technology and invest in cutting-edge medical technology with strong potential for transforming the practice of health care — ideally at a global scale to maximize impact. He and his partners felt strongly that innovations with this kind of impact would likely come from physicians and clinicians on the front lines of medical practice.
“Not only will physicians invent practical medical devices to help their patients — they will also drive the acceptance of these products among their colleagues,” says Otterstatter. “Knowing this, we reached out to Mayo Clinic in 2009 with our prototypes to see if technologies in their IP portfolio aligned in a shared vision.”
Otterstatter found the perfect vision and enabling technology in the BodyGuardian sensor, an on-body device that uses sophisticated algorithms to support remote monitoring and care of patients. The combined device-and-software system allows health care providers to monitor key biometrics outside the clinical setting, while patients go about their daily activities.
“We had the IT knowledge and Mayo had identified a clinical need and developed an enabling device and vision of remote care — it was a perfect intersection of technology and expertise,” he adds.
Integrated, multidisciplinary team
Otterstatter licensed the technology and named the company Preventice in 2010 to commercialize and market the product. Developing BodyGuardian was a multidisciplinary effort that involved Preventice technology experts and Mayo physicians, nurses, engineers and technical staff. Using a small body sensor, the system records and wirelessly transmits important physiological data such as ECG, heart rate, respiration rate and activity level for non-lethal cardiac arrhythmias in ambulatory patients. Remote patient monitoring creates a constant connection between patients and their care teams — potentially easing stress and worry, increasing compliance with treatment plans and improving quality of life.
Expanded applications using the BodyGuardian platform include prescription medication management, cardiac care, sleep apnea and numerous others. In September 2014, Preventice announced a strategic partnership with eCardio Diagnostics LLC to combine their capabilities in remote monitoring systems and mobile health applications. The new company, named Preventice, Inc., is headquartered in Minneapolis and has more than 500 employees. Preventice continues to collaborate with Mayo Clinic Ventures on innovative health care solutions, especially for the emerging market of remote care.
“We could not have achieved this level of success without Mayo Clinic Ventures,” says Otterstatter, president and global strategy officer for Preventice, Inc. “One of the greatest benefits of working with Mayo is its globally recognized brand. It has top-of-the-game physicians — some of the best you will find anywhere. When I look at the structure of our corporate DNA, and how we approach innovation, we could not have done it without listening to the physicians and our colleagues at Mayo.”